Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer. - Wikidata - wikimedia - TriplyDB

Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer.

Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer.

http://www.wikidata.org/entity/Q37289236

about

Paclitaxel with cisplatin in concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma.Definitive radiochemotherapy of advanced head and neck cancer with carboplatin and paclitaxel : a phase II study.Acupuncture for dysphagia after chemoradiation therapy in head and neck cancer: a case series report Supraglottic stenosis: etiology and treatment of a rare condition.Outcomes of serial dilation for high-grade radiation-related esophageal strictures in head and neck cancer patients.Swallowing function following postchemoradiotherapy neck dissection: review of findings and analysis of contributing factors.Neck muscle atrophy and soft-tissue fibrosis after neck dissection and postoperative radiotherapy for oral cancer Head and Neck Cancers, Version 1.2015.Combined antegrade and retrograde esophageal dilation for head and neck cancer-related complete esophageal stenosis.Management of advanced laryngeal cancer.Extent of local invasion and safe resection in cT1-2 tonsil cancer.Effectiveness of chemotherapy and radiotherapy for laryngeal preservation in advanced laryngeal cancer: a meta-analysis and systematic review.Long-term oral effects in patients treated with radiochemotherapy for head and neck cancer.Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma

P2860

Q33386578-21327DAC-265C-4124-BAD2-C322750E1418 Q33397340-DAE15DA2-C985-4889-9028-A9A1DDF7DE04 Q34457352-9CBD439A-E8AB-45B1-8270-912D99AA932D Q34664451-A85194C8-6394-42F1-9E1D-DB8D5F0C0BD8 Q35224516-9E5B2C2B-A05E-40C5-9A92-38000672C6A4 Q36210759-B52337B9-C60B-469D-B1ED-D14359CF4F41 Q36448088-54A0457D-5864-4FB9-84C6-03EC50FBD6C5 Q37157739-E40A2EB2-862A-4075-ABCA-B4B946F982A8 Q37649625-C9EA417B-6402-4F99-B97A-C52DBBB20938 Q38210213-2DE3B806-659D-423B-AEB7-A78279C0FE05 Q38456703-6C79DD7A-A036-4B58-AA5F-C34B576CC623 Q38485149-16D1C085-042E-4198-8BCE-816EA0FE6164 Q48028979-149D3C4F-245C-4912-8A9E-5A90846CD74C Q56779504-584EAE90-F7EF-4F3D-8225-4FFDADE3D577

P2860

Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer.

http://www.wikidata.org/entity/Q37289236

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Long-term outcomes and toxicit ...... advanced head-and-neck cancer.

@en

Long-term outcomes and toxicit ...... advanced head-and-neck cancer.

@nl

type

label

Long-term outcomes and toxicit ...... advanced head-and-neck cancer.

@en

Long-term outcomes and toxicit ...... advanced head-and-neck cancer.

@nl

prefLabel

Long-term outcomes and toxicit ...... advanced head-and-neck cancer.

@en

Long-term outcomes and toxicit ...... advanced head-and-neck cancer.

@nl

P1433

Q37289236-A9F3BCDE-09B6-408D-9A30-90A159E99D12

P1476

Q37289236-01EFE026-3659-4DAB-AB26-4D297151F9F8

P2093

Q37289236-51442868-7C1E-4EAF-A868-370E8CC17583

Q37289236-53274FBE-8785-4A00-8B3D-DA1B336A4D97

Q37289236-5F1B88CF-0800-4C77-84BD-B68E2636CC25

Q37289236-6D74A696-9933-4FF7-841D-299B792D7F83

Q37289236-6EB872A1-7B8D-419F-AE78-ED45633C7017

Q37289236-8D01E902-2484-4A50-9F71-AAC9126E7CEF

Q37289236-A6850FBB-9B4B-4D7A-AA9D-5B5F1CAF0148

Q37289236-A768F81F-9A14-4DB8-842B-F891C60413FC

Q37289236-AD8D598E-6842-4A1A-AAE6-ED877BB32E6D

Q37289236-BBE0CAE3-CE39-437B-A702-8F3CE48A53BE

P2860

Q37289236-0580566F-4CFA-4E81-B536-80104B5B9EFA

Q37289236-06079A94-E6D4-4903-BC9C-8D8ECAF298BF

Q37289236-15D9A888-F28B-4AEE-A557-D27F781A9700

Q37289236-1E157523-B071-451B-A93B-CFABD6C15ABD

Q37289236-56E9CF47-6342-495B-BF0B-C9D573BFE5FA

Q37289236-69BB3B88-7341-4460-B3D5-6012660BB266

Q37289236-6CB4E130-0524-4567-B5C8-EB7DBECB458C

Q37289236-8300D29C-3772-48FE-9D48-CFFFAF53BBC2

Q37289236-8B057A6E-AD8A-4C42-88C3-F37106DE6A5E

Q37289236-8F25CCF7-F6B7-45D2-BF78-B2D4E32D2707

P304

Q37289236-587DAB8B-504D-40BA-9E75-81892FB07A62

P31

Q37289236-2C02F712-D7CB-4C00-A551-BDEC403DF6B1

P356

Q37289236-221FEF9C-B5AD-432C-AFC3-5A3DD126114C

P407

Q37289236-AE9B372A-560B-424B-A057-16AB47F320D6

P433

Q37289236-7EC4715C-B71D-4D20-B222-4208C523AB91

P478

Q37289236-B7999EF2-1291-4EE6-94A9-F245DE5F8784

P577

Q37289236-7D33C7F7-E233-4284-A03A-34437A7EAC2A

P5875

Q37289236-6FCF97B7-9380-4719-97D7-E18E36D8F1CA

P698

Q37289236-E890FCC8-91A1-4F2C-859F-F104A886E383

P921

Q37289236-39EB8460-A592-405F-B469-130DF5C015B9

P932

Q37289236-9BB1A09B-5BD3-433A-BC7D-AC72C068B4BC

P356

J.IJROBP.2008.09.053

P1433

International Journal of Radiation Oncology Biology Physics

P1476

Long-term outcomes and toxicit ...... advanced head-and-neck cancer.

@en

P2093

A Dimitrios Colevas

http://www.w3.org/2001/XMLSchema#string

Ana Cotrim

http://www.w3.org/2001/XMLSchema#string

Angelo Russo

http://www.w3.org/2001/XMLSchema#string

Anna Likhacheva

http://www.w3.org/2001/XMLSchema#string

Beth Solomon

http://www.w3.org/2001/XMLSchema#string

Carter Van Waes

http://www.w3.org/2001/XMLSchema#string

Deborah Citrin

http://www.w3.org/2001/XMLSchema#string

John C Morris

http://www.w3.org/2001/XMLSchema#string

John Mansueti

http://www.w3.org/2001/XMLSchema#string

Laurie Herscher

http://www.w3.org/2001/XMLSchema#string

P2860

Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck.

A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results.

Oral pirfenidone in patients with chronic fibrosis resulting from radiotherapy: a pilot study.

The role of taxanes and targeted therapies in locally advanced head and neck cancer.

Evaluation of early and late toxicities in chemoradiation trials.

Phase II randomized study of concomitant chemoradiation using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced squamous cell carcinoma of the head and neck.

Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol.

Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer.

Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer.

Concomitant twice-a-day radiotherapy and chemotherapy in unresectable head and neck cancer patients: A long-term quality of life analysis.

P304

1040-1046

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJROBP.2008.09.053

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23714894

http://www.w3.org/2001/XMLSchema#string

P698

19117692

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

2720824

http://www.w3.org/2001/XMLSchema#string